{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:30:38Z","timestamp":1781796638440,"version":"3.54.5"},"reference-count":31,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,24]]},"DOI":"10.20945\/2359-3997000000284","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:49:31Z","timestamp":1603306171000},"source":"Crossref","is-referenced-by-count":5,"title":["Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0968-3269","authenticated-orcid":false,"given":"Chandan Kumar","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4077-402X","authenticated-orcid":false,"given":"Anjali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3275-6673","authenticated-orcid":false,"given":"Subhash B.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-2670","authenticated-orcid":false,"given":"Gaurav","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3395-9448","authenticated-orcid":false,"given":"Shalini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4605-3816","authenticated-orcid":false,"given":"Gyan","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-0424","authenticated-orcid":false,"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0635-3897","authenticated-orcid":false,"given":"Saroj Kanta","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20201021144925_B1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1054\/brst.2000.0267","article-title":"Is there a role for iodine in breast diseases?","volume":"10","author":"Venturi","year":"2001","unstructured":"1. Venturi S. Is there a role for iodine in breast diseases? Breast. 2001;10:379-82.","journal-title":"Breast"},{"key":"key20201021144925_B2","first-page":"pii","article-title":"The antigenic link between thyroid autoimmunity and breast cancer","author":"Muller","year":"2019","unstructured":"2. Muller I, Barrett-Lee PJ. The antigenic link between thyroid autoimmunity and breast cancer. Semin Cancer Biol. 2019. pii: S1044-579X(19)30043-4.","journal-title":"Semin Cancer Biol"},{"key":"key20201021144925_B3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1097-0142(19860101)57:1<125::AID-CNCR2820570125>3.0.CO;2-4","article-title":"Thyroid disease in patients with benign and malignant mastopathy","volume":"57","author":"Adamopoulos","year":"1986","unstructured":"3. Adamopoulos DA, Vassilaros S, Kapolla N, Papadiamantis J, Georgiakodis F, Michalakis A. Thyroid disease in patients with benign and malignant mastopathy. Cancer. 1986;57:125-8.","journal-title":"Cancer"},{"key":"key20201021144925_B4","first-page":"504","article-title":"Thyroid disorders and breast cancer","volume":"5","author":"Shering","year":"1996","unstructured":"4. Shering SG, Zbar AP, Moriarty M, McDermott EW, O\u2019Higgins NJ, Smyth PP. Thyroid disorders and breast cancer. Eur J Cancer Prev. 1996;5:504-6.","journal-title":"Eur J Cancer Prev"},{"key":"key20201021144925_B5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.02108","article-title":"Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery","volume":"154","author":"Giustarini","year":"2006","unstructured":"5. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol. 2006;154:645-9.","journal-title":"Eur J Endocrinol"},{"key":"key20201021144925_B6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0100-879X2005000500014","article-title":"Profile of thyroid hormones in breast cancer patients","volume":"38","author":"Saraiva","year":"2005","unstructured":"6. Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res. 2005;38:761-5.","journal-title":"Braz J Med Biol Res"},{"key":"key20201021144925_B7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.20881","article-title":"Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma","volume":"103","author":"Cristofanilli","year":"2005","unstructured":"7. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer. 2005;103:1122-8.","journal-title":"Cancer"},{"key":"key20201021144925_B8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14310\/horm.2002.1152","article-title":"Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis","volume":"1","author":"Sarlis","year":"2002","unstructured":"8. Sarlis N, Gourgiotis L, Pucino F, Tolis GT. Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones (Athens). 2002;1:35-41.","journal-title":"Hormones (Athens)"},{"key":"key20201021144925_B9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10549-012-2019-3","article-title":"Benign thyroid disease is associated with breast cancer: a meta-analysis","volume":"133","author":"Hardefeldt","year":"2012","unstructured":"9. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;133:1169-77.","journal-title":"Breast Cancer Res Treat"},{"key":"key20201021144925_B10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/EJE-11-0838","article-title":"Mechanisms in Endocrinology: Primary HT and risk for breast cancer: a systematic review and meta-analysis","volume":"166","author":"Angelousi","year":"2012","unstructured":"10. Angelousi AG, Anagnostou VK, Stamatakos MK, Georgiopoulos GA, Kontzoglou KC. Mechanisms in Endocrinology: Primary HT and risk for breast cancer: a systematic review and meta-analysis. Eur J Endocrinol. 2012;166:373-81.","journal-title":"Eur J Endocrinol"},{"key":"key20201021144925_B11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40618-017-0679-x","article-title":"Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis","volume":"40","author":"Fang","year":"2017","unstructured":"11. Fang Y, Yao L, Sun J, Yang R, Chen Y, Tian J, et al. Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis. J Endocrinol Invest. 2017;40:1035-47.","journal-title":"J Endocrinol Invest"},{"key":"key20201021144925_B12","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-19-0417","article-title":"Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis","author":"Tran","year":"2020","unstructured":"12. Tran TV, Kitahara CM, de Vathaire F, Boutron-Ruault MC, Journy N. Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis. Endocr Relat Cancer. 2020;ERC-19-0417.R2.","journal-title":"Endocr Relat Cancer"},{"key":"key20201021144925_B13","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/ERC-12-0219","article-title":"Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective","volume":"20","author":"Moeller","year":"2013","unstructured":"13. Moeller LC, F\u00fchrer D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer. 2013;20:R19-29.","journal-title":"Endocr Relat Cancer"},{"key":"key20201021144925_B14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijrobp.2008.11.037","article-title":"Thyroid function in women after multimodal treatment for breast cancer stage II\/III: comparison with controls from a population sample","volume":"75","author":"Reinertsen","year":"2009","unstructured":"14. Reinertsen KV, Cvancarova M, Wist E, Bj\u00f8ro T, Dahl AA, Danielsen T, et al. Thyroid function in women after multimodal treatment for breast cancer stage II\/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75:764-70.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20201021144925_B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0167-8140(01)00284-5","article-title":"Does the tamoxifen increase thyroid dysfunction after loco-regional irradiation of breast cancer?","volume":"59","author":"Koc","year":"2001","unstructured":"15. Koc M, Capoglu I, Unuvar N. Does the tamoxifen increase thyroid dysfunction after loco-regional irradiation of breast cancer? Radiother Oncol. 2001;59:361-2.","journal-title":"Radiother Oncol"},{"key":"key20201021144925_B16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.28493","article-title":"Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer?","volume":"134","author":"Muller","year":"2014","unstructured":"16. Muller I, Giani C, Zhang L, Grennan-Jones FA, Fiore E, Belardi V, et al. Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer. 2014;134:1706-14.","journal-title":"Int J Cancer"},{"key":"key20201021144925_B17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/BF03350810","article-title":"Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer","volume":"30","author":"Fiore","year":"2007","unstructured":"17. Fiore E, Giustarini E, Mammoli C, Fragomeni F, Campani D, Muller I, et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer. J Endocrinol Invest. 2007;30:734-8.","journal-title":"J Endocrinol Invest"},{"key":"key20201021144925_B18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-008-0104-4","article-title":"Autoimmune hypothyroidism and breast cancer in the elderly","volume":"115","author":"Sandhu","year":"2009","unstructured":"18. Sandhu MK, Brezden-Masley C, Lipscombe LL, Zagorski B, Booth GL. Autoimmune hypothyroidism and breast cancer in the elderly. Breast Cancer Res Treat. 2009;115:635-41.","journal-title":"Breast Cancer Res Treat"},{"key":"key20201021144925_B19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/1471-2407-13-334","article-title":"Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine","volume":"13","author":"Huang","year":"2013","unstructured":"19. Huang J, Jin L, Ji G, Xing L, Xu C, Xiong X, et al. Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine. BMC Cancer. 2013;13:334.","journal-title":"BMC Cancer"},{"key":"key20201021144925_B20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","unstructured":"20. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine PracT. 2012;18:988-1028.","journal-title":"Endocrine PracT"},{"key":"key20201021144925_B21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00268-009-0143-y","article-title":"Prevalence of Hypothyroidism in Benign Breast Disorders and Effect of Thyroxine Replacement on the Clinical Outcome","volume":"33","author":"Bhargav","year":"2009","unstructured":"21. Bhargav PR, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK. Prevalence of Hypothyroidism in Benign Breast Disorders and Effect of Thyroxine Replacement on the Clinical Outcome. World J Surg. 2009;33:2087-93.","journal-title":"World J Surg"},{"key":"key20201021144925_B22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1017\/S1368980009990280","article-title":"Persistence of severe iodine-deficiency disorders despite universal salt iodization in an iodine-deficient area in northern India","volume":"13","author":"Yadav","year":"2010","unstructured":"22. Yadav S, Gupta SK, Godbole MM, Jain M, Singh U, Pavithran PV, et al. Persistence of severe iodine-deficiency disorders despite universal salt iodization in an iodine-deficient area in northern India. Public Health Nutr. 2010;13:424-9.","journal-title":"Public Health Nutr"},{"key":"key20201021144925_B23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","unstructured":"23. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47.","journal-title":"Eur J Cancer"},{"key":"key20201021144925_B24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.1982.tb00720.x","article-title":"Alterations in thyroid hormone metabolism during chemotherapy in patients with testicular carcinoma","volume":"16","author":"Willemse","year":"1982","unstructured":"24. Willemse PH, Sleijfer DT, Sluiter WJ, Koops HS, Doorenbos H. Alterations in thyroid hormone metabolism during chemotherapy in patients with testicular carcinoma. Clin Endocrinol (Oxf). 1982;16:303-13.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20201021144925_B25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3892\/or.2013.2648","article-title":"Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors","volume":"30","author":"L\u00f3pez-Fontana","year":"2013","unstructured":"25. L\u00f3pez-Fontana CM, Sasso CV, Maselli ME, Santiano FE, Semino SN, Carri\u00f3n FDC, et al. Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors. Oncol Rep. 2013;30:1651-60.","journal-title":"Oncol Rep"},{"key":"key20201021144925_B26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1991.1.235","article-title":"Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness?","volume":"1","author":"Poth","year":"1991","unstructured":"26. Poth M, Tseng YC, Wartofsky L. Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness? Thyroid. 1991;1:235-40.","journal-title":"Thyroid"},{"key":"key20201021144925_B27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/thy.1993.3.325","article-title":"Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-alpha","volume":"3","author":"Pang","year":"1993","unstructured":"27. Pang XP, Yoshimura M, Hershman JM. Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-alpha. Thyroid. 1993;3:325-30.","journal-title":"Thyroid"},{"key":"key20201021144925_B28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0167-8140(00)00183-3","article-title":"Severe hypothyroidism after chemotherapy and locoregional irradiation for breast cancer","volume":"57","author":"Cutuli","year":"2000","unstructured":"28. Cutuli B, Quentin P, Rodier JF, Barakat P, Grob JC. Severe hypothyroidism after chemotherapy and locoregional irradiation for breast cancer. Radiother Oncol. 2000;57:103-5.","journal-title":"Radiother Oncol"},{"key":"key20201021144925_B29","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.4103\/2230-8210.104078","article-title":"Incidence of primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland","volume":"16","author":"Laway","year":"2012","unstructured":"29. Laway BA, Shafi KM, Majid S, Lone MM, Afroz F, Khan S, et al. Incidence of primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland. Indian J Endocrinol Metab. 2012;16(Suppl 2):S329-31.","journal-title":"Indian J Endocrinol Metab"},{"key":"key20201021144925_B30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/cncr.23307","article-title":"Risk of Hypothyroidism in Older Breast Cancer Patients Treated With Radiation","volume":"112","author":"Smith","year":"2008","unstructured":"30. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, et al. Risk of Hypothyroidism in Older Breast Cancer Patients Treated With Radiation. Cancer. 2008;112:1371-9.","journal-title":"Cancer"},{"key":"key20201021144925_B31","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s12094-018-1875-7","article-title":"Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis","volume":"20","author":"Darvish","year":"2018","unstructured":"31. Darvish L, Ghorbani M, Teshnizi SH, Roozbeh N, Seif F, Reza Bayatiani M, et al. Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis. Clin Transl Oncol. 2018;20:1430-8.","journal-title":"Clin Transl Oncol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T05:24:10Z","timestamp":1669267450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005006207&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":31,"alternative-id":["10.20945\/2359-3997000000284"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000284","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]}}}